Next Article in Journal
A New High-Throughput LC-MS/MS Assay for Therapeutic Level Monitoring of Valproic Acid in Human Plasma
Previous Article in Journal
Synthesis and Preclinical Studies of [61Cu]-N-(2-hydroxyacetophenone)glycinate as a Possible PET Radiopharmaceutical
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 76
Issue 4
10.3797/scipharm.0808-08
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Spectral Characterization of Degradation Impurities of Paroxetine Hydrochloride Hemihydrate

by
Nirmala MUNIGELA
1,*,
J. Moses BABU
1,
Anjaneyulu YERRAMILLI
3,
Naveen Kumar KOLLA
2,
Vyas KRISHNAMURTHY
1 and
Vijay Vittal MATHAD
2
1
Department of Analytical Research, Discovery Research, Dr. Reddy’s Laboratories, Bollaram Road, Miyapur, Hyderabad 500 049, India
2
Research and development, Dr. Reddy’s Laboratories Ltd., Integrated Product Development, Unit-III, Plot No.116, S.V. Co-Op.Indl. Estate, Bollaram, Jinnaram, Medak-502 325, India
3
Jawaharlal Nehru Technological University, Kukatpally, Hyderabad-500 072, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2008, 76(4), 653-662; https://doi.org/10.3797/scipharm.0808-08
Submission received: 10 August 2008 / Accepted: 14 September 2008 / Published: 23 September 2008
Versions Notes

Abstract

Two unknown impurities were detected in stressed samples (by hydrochloric acid and hydrogen peroxide) of paroxetine hydrochloride hemihydrate (an active pharmaceutical ingredient – API) using a gradient reversed-phase high performance liquid chromatography (HPLC). These impurities were enriched and were present up to 30% in the degraded sample. The impurities were isolated from the degraded sample by column purification. Spectral data of the isolated impurities were collected. Based on the spectral data of two dimensional nuclear magnetic spectroscopy (2D-NMR) and mass spectrometry (MS) Impurity-1 and Impurity-2 were characterized as (3S,4R)-3-{[(6-chloro-1,3-benzodioxol-5-yl)oxy]methyl}-4-(4-fluorophenyl)piperidine and [(3S,4R)-4-(4-fluorophenyl)piperidin-3-yl]methanol respectively.
Keywords: Paroxetine; Degradation; NMR; HPLC; LC-MS Paroxetine; Degradation; NMR; HPLC; LC-MS

Share and Cite

MDPI and ACS Style

MUNIGELA, N.; BABU, J.M.; YERRAMILLI, A.; KOLLA, N.K.; KRISHNAMURTHY, V.; MATHAD, V.V. Spectral Characterization of Degradation Impurities of Paroxetine Hydrochloride Hemihydrate. Sci. Pharm. 2008, 76, 653-662. https://doi.org/10.3797/scipharm.0808-08

AMA Style

MUNIGELA N, BABU JM, YERRAMILLI A, KOLLA NK, KRISHNAMURTHY V, MATHAD VV. Spectral Characterization of Degradation Impurities of Paroxetine Hydrochloride Hemihydrate. Scientia Pharmaceutica. 2008; 76(4):653-662. https://doi.org/10.3797/scipharm.0808-08

Chicago/Turabian Style

MUNIGELA, Nirmala, J. Moses BABU, Anjaneyulu YERRAMILLI, Naveen Kumar KOLLA, Vyas KRISHNAMURTHY, and Vijay Vittal MATHAD. 2008. "Spectral Characterization of Degradation Impurities of Paroxetine Hydrochloride Hemihydrate" Scientia Pharmaceutica 76, no. 4: 653-662. https://doi.org/10.3797/scipharm.0808-08

APA Style

MUNIGELA, N., BABU, J. M., YERRAMILLI, A., KOLLA, N. K., KRISHNAMURTHY, V., & MATHAD, V. V. (2008). Spectral Characterization of Degradation Impurities of Paroxetine Hydrochloride Hemihydrate. Scientia Pharmaceutica, 76(4), 653-662. https://doi.org/10.3797/scipharm.0808-08

Article Metrics

Back to TopTop